Matches in Wikidata for { <http://www.wikidata.org/entity/Q92037935> ?p ?o ?g. }
Showing items 1 to 56 of
56
with 100 items per page.
- Q92037935 description "article scientifique publié en 2019" @default.
- Q92037935 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q92037935 description "scientific article published on 19 July 2019" @default.
- Q92037935 description "wetenschappelijk artikel" @default.
- Q92037935 description "наукова стаття, опублікована 19 липня 2019" @default.
- Q92037935 name "Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma" @default.
- Q92037935 name "Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma" @default.
- Q92037935 type Item @default.
- Q92037935 label "Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma" @default.
- Q92037935 label "Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma" @default.
- Q92037935 prefLabel "Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma" @default.
- Q92037935 prefLabel "Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma" @default.
- Q92037935 P1433 Q92037935-01F97C44-D43B-4EF9-9563-263721C0C318 @default.
- Q92037935 P1476 Q92037935-B50A9135-0597-4688-BD4E-DE38AADBC98F @default.
- Q92037935 P2093 Q92037935-4C065A5B-B575-48AA-8E94-91E2B99EAB89 @default.
- Q92037935 P2093 Q92037935-5970FB4F-3FA3-4BCD-8545-CECD66E659BA @default.
- Q92037935 P2093 Q92037935-6CAD8151-B998-49F7-98DF-A546361ECBC4 @default.
- Q92037935 P2093 Q92037935-75440B90-EE5C-483D-8EEC-0FCF625584C9 @default.
- Q92037935 P2093 Q92037935-75E1B506-1CB1-417C-8F11-FF5320F52976 @default.
- Q92037935 P304 Q92037935-C41C12FC-DEF8-44A2-A30B-E4396B75E7A2 @default.
- Q92037935 P31 Q92037935-8CA64439-298D-4069-91A8-E957FFA8601A @default.
- Q92037935 P356 Q92037935-0BFA423A-1720-4044-9862-9CEE646ED2A0 @default.
- Q92037935 P433 Q92037935-8514F46C-3FDD-4B98-A3F1-25E790ACA6F2 @default.
- Q92037935 P478 Q92037935-CB9FD828-F3AA-4163-B5DB-2F9BCD93E3F9 @default.
- Q92037935 P50 Q92037935-3F0C3F56-1364-4E04-B414-4FA963778219 @default.
- Q92037935 P50 Q92037935-6CC52E11-1529-40D7-A87A-D3FC221AAB69 @default.
- Q92037935 P50 Q92037935-8853916A-F31B-4EAA-9734-8A175C2D128D @default.
- Q92037935 P50 Q92037935-9ABC7DFB-54AA-4432-8A98-EFF5D81DCE15 @default.
- Q92037935 P577 Q92037935-B31D8438-F53C-4B48-9871-3E9BCEDC9FC6 @default.
- Q92037935 P698 Q92037935-D9EEA726-49CC-4188-A9C9-255D5471D763 @default.
- Q92037935 P921 Q92037935-14C0320E-3DE5-438C-90C9-0F9E87452B2D @default.
- Q92037935 P921 Q92037935-5B2857D7-DB58-4990-9436-3552B1E47BB6 @default.
- Q92037935 P932 Q92037935-15BEF12E-E9B8-4182-9DC8-E25C940E4940 @default.
- Q92037935 P356 S11060-019-03243-7 @default.
- Q92037935 P698 31325145 @default.
- Q92037935 P1433 Q15752119 @default.
- Q92037935 P1476 "Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma" @default.
- Q92037935 P2093 "Andrew B Lassman" @default.
- Q92037935 P2093 "Craig Nolan" @default.
- Q92037935 P2093 "Igor T Gavrilovic" @default.
- Q92037935 P2093 "Ingo K Mellinghoff" @default.
- Q92037935 P2093 "Lisa M DeAngelis" @default.
- Q92037935 P304 "403-407" @default.
- Q92037935 P31 Q13442814 @default.
- Q92037935 P356 "10.1007/S11060-019-03243-7" @default.
- Q92037935 P433 "2" @default.
- Q92037935 P478 "144" @default.
- Q92037935 P50 Q114408547 @default.
- Q92037935 P50 Q114444382 @default.
- Q92037935 P50 Q55458994 @default.
- Q92037935 P50 Q89747805 @default.
- Q92037935 P577 "2019-07-19T00:00:00Z" @default.
- Q92037935 P698 "31325145" @default.
- Q92037935 P921 Q282142 @default.
- Q92037935 P921 Q42824440 @default.
- Q92037935 P932 "7493746" @default.